By Fineline Cube 
China-based medical imaging expert Jiangxi Rimag Group Co., Ltd (HKG: 2522) has announced the successful listing of its CT chest lesion annotation data on the Shanghai Data Exchange. The data has passed the compliance review by the big data comprehensive trading institution, marking a significant milestone in the company’s data commercialization efforts.
Technical Advantages
Rimag Group has developed an in-house Yimai Cloud platform, enabling the establishment of a full-chain technical system that covers data collection, data standards, data cleaning, and data analysis. This integrated approach ensures high-quality data processing and utilization.
AI Model Training
The company’s “standardized coding + refined annotation” model provides high-quality data for AI model training. This model highlights Rimag’s leading advantage in transforming raw data into intelligent applications, supporting advancements in medical imaging technology and AI-driven diagnostic solutions.-Fineline Info & Tech